{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:00Z","timestamp":1787003820015,"version":"build-2736575974"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V010182\/1"],"award-info":[{"award-number":["MR\/V010182\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["097812\/Z\/11\/Z"],"award-info":[{"award-number":["097812\/Z\/11\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"RCUK | Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/N034295\/1"],"award-info":[{"award-number":["EP\/N034295\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Uterine fibroids (UFs), benign tumours prevalent in up to 80% of women of reproductive age, are associated with significant morbidity, including abnormal uterine bleeding, pain and infertility. Despite identification of key genomic alterations in\n                      <jats:italic>MED12<\/jats:italic>\n                      and\n                      <jats:italic>HMGA2<\/jats:italic>\n                      , the pathogenic mechanisms underlying UFs and heavy menstrual bleeding (HMB) remain poorly understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To correlate systematically genetic, transcriptional and proteomic phenotypes, we conducted an integrative multi-omic approach utilising targeted DNA sequencing, RNA sequencing and proteomic methodologies, encompassing fibroid, myometrium, and endometrium tissues from 91 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In addition to confirming the presence of\n                      <jats:italic>MED12<\/jats:italic>\n                      mutations, we identify variants in\n                      <jats:italic>AHR<\/jats:italic>\n                      and\n                      <jats:italic>COL4A6<\/jats:italic>\n                      . Multi-omic analysis of endometrium identifies latent factors that correlate with HMB and fibroid presence with driver mutations of\n                      <jats:italic>MED12<\/jats:italic>\n                      ,\n                      <jats:italic>AHR<\/jats:italic>\n                      , and\n                      <jats:italic>COL4A6<\/jats:italic>\n                      , which are associated with pathways involved in angiogenesis, extracellular matrix organisation and RNA splicing. We propose a model, supported by in vivo evidence, where altered signalling of\n                      <jats:italic>MED12<\/jats:italic>\n                      -mutated fibroids influences RNA transcript isoform expression in endometrium, potentially leading to abnormal uterine bleeding.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study presents a comprehensive integrative approach, revealing that genetic alterations in UF may influence endometrial function via signalling impacts on the RNA splicing mechanism. Our findings advance the understanding of complex molecular pathways in UF pathogenesis and UF-associated endometrial dysfunction, offering insights for targeted therapeutic development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-025-01051-x","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T01:27:15Z","timestamp":1753925235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding"],"prefix":"10.1038","volume":"5","author":[{"given":"Chen-Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Philpott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-7795","authenticated-orcid":false,"given":"Darragh","family":"P O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ndungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Malzahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Maritati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-4556","authenticated-orcid":false,"given":"Beatriz","family":"Martinez-Burgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bonham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9715-5951","authenticated-orcid":false,"given":"Roman","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9543-2110","authenticated-orcid":false,"given":"Kurtis","family":"Garbutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-9581","authenticated-orcid":false,"given":"Christian M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Manek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-8409","authenticated-orcid":false,"given":"Adrian L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Obendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6295-1221","authenticated-orcid":false,"given":"J\u00f6rg","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Zollner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-9905","authenticated-orcid":false,"given":"Krina T.","family":"Zondervan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-2446","authenticated-orcid":false,"given":"Benedikt M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9984-5342","authenticated-orcid":false,"given":"Udo","family":"Oppermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-3077","authenticated-orcid":false,"given":"Adam P.","family":"Cribbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird, D. D., Dunson, D. B., Hill, M. C., Cousins, D. & Schectman, J. M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am. J. Obstet. Gynecol. 188, 100\u2013107 (2003).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1051_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","volume":"22","author":"S Gupta","year":"2008","unstructured":"Gupta, S., Jose, J. & Manyonda, I. Clinical presentation of fibroids. Best. Pr. Res Clin. Obstet. Gynaecol. 22, 615\u2013626 (2008).","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"1051_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/GCO.0000000000000185","volume":"27","author":"MB Moravek","year":"2015","unstructured":"Moravek, M. B. & Bulun, S. E. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Curr. Opin. Obstet. Gynecol. 27, 276\u2013283 (2015).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"1051_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/cells12081117","volume":"12","author":"M Ali","year":"2023","unstructured":"Ali, M. et al. Progesterone signaling and uterine fibroid pathogenesis; molecular mechanisms and potential therapeutics. Cells 12, 1117 (2023).","journal-title":"Cells"},{"key":"1051_CR5","doi-asserted-by":"publisher","first-page":"123345","DOI":"10.1016\/j.lfs.2024.123345","volume":"362","author":"I Ploumaki","year":"2025","unstructured":"Ploumaki, I., Macri, V. I., Segars, J. H. & Islam, M. S. Progesterone signaling in uterine fibroids: Molecular mechanisms and therapeutic opportunities. Life Sci. 362, 123345 (2025).","journal-title":"Life Sci."},{"key":"1051_CR6","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","volume":"372","author":"EA Stewart","year":"2015","unstructured":"Stewart, E. A. Clinical practice. Uterine fibroids. N. Engl. J. Med. 372, 1646\u20131655 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1051_CR7","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1097\/01.AOG.0000210640.86628.ff","volume":"107","author":"GF Jacobson","year":"2006","unstructured":"Jacobson, G. F., Shaber, R. E., Armstrong, M. A. & Hung, Y. Y. Hysterectomy rates for benign indications. Obstet. Gynecol. 107, 1278\u20131283 (2006).","journal-title":"Obstet. Gynecol."},{"key":"1051_CR8","doi-asserted-by":"publisher","first-page":"211 e211","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo, E. R. et al. The estimated annual cost of uterine leiomyomata in the United States. Am. J. Obstet. Gynecol. 206, 211 e211\u2013e219 (2012).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1051_CR9","first-page":"431","volume":"101","author":"G Wegienka","year":"2003","unstructured":"Wegienka, G. et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet. Gynecol. 101, 431\u2013437 (2003).","journal-title":"Obstet. Gynecol."},{"key":"1051_CR10","first-page":"1222","volume":"108","author":"KG Cooper","year":"2001","unstructured":"Cooper, K. G., Jack, S. A., Parkin, D. E. & Grant, A. M. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. BJOG 108, 1222\u20131228 (2001).","journal-title":"BJOG"},{"key":"1051_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1098-3597(00)90019-X","volume":"3","author":"A Goodman","year":"2000","unstructured":"Goodman, A. Abnormal genital tract bleeding. Clin. Cornerstone 3, 25\u201335 (2000).","journal-title":"Clin. Cornerstone"},{"key":"1051_CR12","first-page":"3","volume":"12","author":"DK Hapangama","year":"2016","unstructured":"Hapangama, D. K. & Bulmer, J. N. Pathophysiology of heavy menstrual bleeding. Women\u2019s. Health 12, 3\u201313 (2016).","journal-title":"Women\u2019s. Health"},{"key":"1051_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N Makinen","year":"2011","unstructured":"Makinen, N. et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334, 252\u2013255 (2011).","journal-title":"Science"},{"key":"1051_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine, M. et al. Characterization of uterine leiomyomas by whole-genome sequencing. N. Engl. J. Med. 369, 43\u201353 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1051_CR15","doi-asserted-by":"publisher","first-page":"15788","DOI":"10.1073\/pnas.0607483103","volume":"103","author":"H Elmlund","year":"2006","unstructured":"Elmlund, H. et al. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II. Proc. Natl. Acad. Sci. USA 103, 15788\u201315793 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1051_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1158\/1541-7786.MCR-06-0331","volume":"5","author":"I Cleynen","year":"2007","unstructured":"Cleynen, I. et al. HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB. Mol. Cancer Res. 5, 363\u2013372 (2007).","journal-title":"Mol. Cancer Res."},{"key":"1051_CR17","doi-asserted-by":"publisher","first-page":"17053","DOI":"10.1073\/pnas.1313650110","volume":"110","author":"M Ono","year":"2013","unstructured":"Ono, M. et al. Paracrine activation of WNT\/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc. Natl. Acad. Sci. USA 110, 17053\u201317058 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1051_CR18","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","volume":"2","author":"EA Stewart","year":"2016","unstructured":"Stewart, E. A. et al. Uterine fibroids. Nat. Rev. Dis. Prim. 2, 16043 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1051_CR19","doi-asserted-by":"publisher","first-page":"101662","DOI":"10.1016\/j.arr.2022.101662","volume":"79","author":"CE Yang","year":"2022","unstructured":"Yang, C. E. et al. Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis. Ageing Res. Rev. 79, 101662 (2022).","journal-title":"Ageing Res. Rev."},{"key":"1051_CR20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine, M. et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc. Natl. Acad. Sci. USA 113, 1315\u20131320 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1051_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/humrep\/deh698","volume":"20","author":"AA Arslan","year":"2005","unstructured":"Arslan, A. A. et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum. Reprod. 20, 852\u2013863 (2005).","journal-title":"Hum. Reprod."},{"key":"1051_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/hmg\/ddi431","volume":"15","author":"S Vanharanta","year":"2006","unstructured":"Vanharanta, S. et al. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. Hum. Mol. Genet. 15, 97\u2013103 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"1051_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gcc.20291","volume":"45","author":"NC Christacos","year":"2006","unstructured":"Christacos, N. C., Quade, B. J., Dal Cin, P. & Morton, C. C. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer 45, 304\u2013312 (2006).","journal-title":"Genes Chromosomes Cancer"},{"key":"1051_CR24","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.1038\/sj.onc.1208784","volume":"24","author":"S Vanharanta","year":"2005","unstructured":"Vanharanta, S. et al. 7q deletion mapping and expression profiling in uterine fibroids. Oncogene 24, 6545\u20136554 (2005).","journal-title":"Oncogene"},{"key":"1051_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","volume":"195","author":"PC Leppert","year":"2006","unstructured":"Leppert, P. C., Catherino, W. H. & Segars, J. H. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am. J. Obstet. Gynecol. 195, 415\u2013420 (2006).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1051_CR26","doi-asserted-by":"publisher","first-page":"e12362","DOI":"10.1371\/journal.pone.0012362","volume":"5","author":"J Zavadil","year":"2010","unstructured":"Zavadil, J. et al. Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas. PLoS One 5, e12362 (2010).","journal-title":"PLoS One"},{"key":"1051_CR27","doi-asserted-by":"crossref","unstructured":"Hodge, J. C. et al. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity. Hum. Mol. Genet 21, 2312\u20132329 (2012).","DOI":"10.1093\/hmg\/dds051"},{"key":"1051_CR28","doi-asserted-by":"publisher","first-page":"e57901","DOI":"10.1371\/journal.pone.0057901","volume":"8","author":"PD Cirilo","year":"2013","unstructured":"Cirilo, P. D. An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas. PLoS One 8, e57901 (2013).","journal-title":"PLoS One"},{"key":"1051_CR29","first-page":"61","volume":"155","author":"YA Ko","year":"2018","unstructured":"Ko, Y. A. et al. Extracellular matrix (ECM) activates beta-catenin signaling in uterine fibroids. Reproduction 155, 61\u201371 (2018).","journal-title":"Reproduction"},{"key":"1051_CR30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1210\/en.2017-03018","volume":"159","author":"MFB Jamaluddin","year":"2018","unstructured":"Jamaluddin, M. F. B. et al. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin. Endocrinology 159, 1106\u20131118 (2018).","journal-title":"Endocrinology"},{"key":"1051_CR31","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1210\/en.2018-00151","volume":"159","author":"MFB Jamaluddin","year":"2018","unstructured":"Jamaluddin, M. F. B., Nahar, P. & Tanwar, P. S. Proteomic characterization of the extracellular matrix of human uterine fibroids. Endocrinology 159, 2656\u20132669 (2018).","journal-title":"Endocrinology"},{"key":"1051_CR32","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/1933719118773420","volume":"26","author":"MFB Jamaluddin","year":"2019","unstructured":"Jamaluddin, M. F. B., Nagendra, P. B., Nahar, P., Oldmeadow, C. & Tanwar, P. S. Proteomic analysis identifies Tenascin-C expression is upregulated in uterine fibroids. Reprod. Sci. 26, 476\u2013486 (2019).","journal-title":"Reprod. Sci."},{"key":"1051_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","journal-title":"Gigascience"},{"key":"1051_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"1051_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"1051_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1051_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"1051_CR38","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovations 2, 100141 (2021).","journal-title":"Innovations"},{"key":"1051_CR39","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).","journal-title":"F1000Res"},{"key":"1051_CR40","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.12688\/f1000research.8900.2","volume":"5","author":"M Nowicka","year":"2016","unstructured":"Nowicka, M. & Robinson, M. D. DRIMSeq: a Dirichlet-multinomial framework for multivariate count outcomes in genomics. F1000Res 5, 1356 (2016).","journal-title":"F1000Res"},{"key":"1051_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1277-0","volume":"18","author":"K Van den Berge","year":"2017","unstructured":"Van den Berge, K., Soneson, C., Robinson, M. D. & Clement, L. stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage. Genome Biol. 18, 151 (2017).","journal-title":"Genome Biol."},{"key":"1051_CR42","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/bioinformatics\/btv494","volume":"31","author":"U Bodenhofer","year":"2015","unstructured":"Bodenhofer, U., Bonatesta, E., Horejs-Kainrath, C. & Hochreiter, S. msa: an R package for multiple sequence alignment. Bioinformatics 31, 3997\u20133999 (2015).","journal-title":"Bioinformatics"},{"key":"1051_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwz072","author":"MB Dragicevic","year":"2019","unstructured":"Dragicevic, M. B., Paunovic, D. M., Bogdanovic, M. D., Todorovic, S. I. & Simonovic, A. D. ragp: Pipeline for mining of plant hydroxyproline-rich glycoproteins with implementation in R. Glycobiology https:\/\/doi.org\/10.1093\/glycob\/cwz072 (2019).","journal-title":"Glycobiology"},{"key":"1051_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"1051_CR45","doi-asserted-by":"publisher","first-page":"e8124","DOI":"10.15252\/msb.20178124","volume":"14","author":"R Argelaguet","year":"2018","unstructured":"Argelaguet, R. et al. Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets. Mol. Syst. Biol. 14, e8124 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"1051_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02015-1","volume":"21","author":"R Argelaguet","year":"2020","unstructured":"Argelaguet, R. et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 21, 111 (2020).","journal-title":"Genome Biol."},{"key":"1051_CR47","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1051_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41592-019-0654-x","volume":"17","author":"RA Amezquita","year":"2020","unstructured":"Amezquita, R. A. et al. Orchestrating single-cell analysis with Bioconductor. Nat. Methods 17, 137\u2013145 (2020).","journal-title":"Nat. Methods"},{"key":"1051_CR49","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"1051_CR50","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"PL Germain","year":"2021","unstructured":"Germain, P. L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res 10, 979 (2021).","journal-title":"F1000Res"},{"key":"1051_CR51","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"1051_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"1051_CR53","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"key":"1051_CR54","doi-asserted-by":"publisher","unstructured":"Wyman, D. et al. A technology-agnostic long-read analysis pipeline for transcriptome discovery and quantification. bioRxiv. https:\/\/doi.org\/10.1101\/672931 (2020).","DOI":"10.1101\/672931"},{"key":"1051_CR55","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/bioinformatics\/btaa836","volume":"37","author":"F Reese","year":"2021","unstructured":"Reese, F. & Mortazavi, A. Swan: a library for the analysis and visualization of long-read transcriptomes. Bioinformatics 37, 1322\u20131323 (2021).","journal-title":"Bioinformatics"},{"key":"1051_CR56","doi-asserted-by":"publisher","first-page":"e41800","DOI":"10.1371\/journal.pone.0041800","volume":"7","author":"A Menning","year":"2012","unstructured":"Menning, A. et al. Granulocytes and vascularization regulate uterine bleeding and tissue remodeling in a mouse menstruation model. PLoS One 7, e41800 (2012).","journal-title":"PLoS One"},{"key":"1051_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1530\/jrf.0.0990219","volume":"99","author":"PE Cohen","year":"1993","unstructured":"Cohen, P. E. & Milligan, S. R. Silastic implants for delivery of oestradiol to mice. J. Reprod. Fertil. 99, 219\u2013223 (1993).","journal-title":"J. Reprod. Fertil."},{"key":"1051_CR58","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/00365516409060511","volume":"16","author":"L Hallberg","year":"1964","unstructured":"Hallberg, L. & Nilsson, L. Determination of Menstrual Blood Loss. Scand. J. Clin. Lab Invest. 16, 244\u2013248 (1964).","journal-title":"Scand. J. Clin. Lab Invest."},{"key":"1051_CR59","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/cmdc.201500442","volume":"10","author":"IV Hartung","year":"2015","unstructured":"Hartung, I. V. et al. Modular Assembly of Allosteric MEK inhibitor structural elements unravels potency and feedback-modulation handles. ChemMedChem 10, 2004\u20132013 (2015).","journal-title":"ChemMedChem"},{"key":"1051_CR60","first-page":"911","volume":"150","author":"AJ Williams","year":"1997","unstructured":"Williams, A. J., Powell, W. L., Collins, T. & Morton, C. C. HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am. J. Pathol. 150, 911\u2013918 (1997).","journal-title":"Am. J. Pathol."},{"key":"1051_CR61","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.fertnstert.2016.10.035","volume":"107","author":"SA Yatsenko","year":"2017","unstructured":"Yatsenko, S. A. et al. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays. Fertil. Steril. 107, 457\u2013466.e459 (2017).","journal-title":"Fertil. Steril."},{"key":"1051_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/gcc.22001","volume":"52","author":"EF Schoenmakers","year":"2013","unstructured":"Schoenmakers, E. F. et al. Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma. Genes Chromosomes Cancer 52, 11\u201323 (2013).","journal-title":"Genes Chromosomes Cancer"},{"key":"1051_CR63","first-page":"181","volume":"12","author":"V Medikare","year":"2011","unstructured":"Medikare, V., Kandukuri, L. R., Ananthapur, V., Deenadayal, M. & Nallari, P. The genetic bases of uterine fibroids; a review. J. Reprod. Infertil. 12, 181\u2013191 (2011).","journal-title":"J. Reprod. Infertil."},{"key":"1051_CR64","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/humupd\/dmv038","volume":"21","author":"JA Maybin","year":"2015","unstructured":"Maybin, J. A. & Critchley, H. O. Menstrual physiology: implications for endometrial pathology and beyond. Hum. Reprod. Update 21, 748\u2013761 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"1051_CR65","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1160\/TH11-04-0274","volume":"106","author":"MV Ragni","year":"2011","unstructured":"Ragni, M. V. et al. Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia. Thromb. Haemost. 106, 641\u2013645 (2011).","journal-title":"Thromb. Haemost."},{"key":"1051_CR66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12905-020-0887-y","volume":"20","author":"JL Magnay","year":"2020","unstructured":"Magnay, J. L., O\u2019Brien, S., Gerlinger, C. & Seitz, C. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Women\u2019s. Health 20, 24 (2020).","journal-title":"BMC Women\u2019s. Health"},{"key":"1051_CR67","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","volume":"124","author":"RA Brodsky","year":"2014","unstructured":"Brodsky, R. A. Paroxysmal nocturnal hemoglobinuria. Blood 124, 2804\u20132811 (2014).","journal-title":"Blood"},{"key":"1051_CR68","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1021\/bi9005094","volume":"48","author":"KA Dickson","year":"2009","unstructured":"Dickson, K. A. et al. Ribonuclease inhibitor regulates neovascularization by human angiogenin. Biochemistry 48, 3804\u20133806 (2009).","journal-title":"Biochemistry"},{"key":"1051_CR69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41416-021-01516-5","volume":"126","author":"M Mondal","year":"2022","unstructured":"Mondal, M., Conole, D., Nautiyal, J. & Tate, E. W. UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology. Br. J. Cancer 126, 24\u201333 (2022).","journal-title":"Br. J. Cancer"},{"key":"1051_CR70","doi-asserted-by":"publisher","unstructured":"Suzuki, T. et al. Pivotal Role of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) in Uterine Leiomyoma. Biomolecules 13, https:\/\/doi.org\/10.3390\/biom13020193 (2023).","DOI":"10.3390\/biom13020193"},{"key":"1051_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-S16-S12","volume":"13","author":"J Cox","year":"2012","unstructured":"Cox, J. & Mann, M. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinforma. 13, S12 (2012).","journal-title":"BMC Bioinforma."},{"key":"1051_CR72","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/emboj\/20.3.480","volume":"20","author":"D Rotzer","year":"2001","unstructured":"Rotzer, D. et al. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. EMBO J. 20, 480\u2013490 (2001).","journal-title":"EMBO J."},{"key":"1051_CR73","doi-asserted-by":"publisher","first-page":"22765","DOI":"10.1074\/jbc.M401350200","volume":"279","author":"E del Re","year":"2004","unstructured":"del Re, E., Babitt, J. L., Pirani, A., Schneyer, A. L. & Lin, H. Y. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. J. Biol. Chem. 279, 22765\u201322772 (2004).","journal-title":"J. Biol. Chem."},{"key":"1051_CR74","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/excr.1996.0066","volume":"223","author":"R Hirai","year":"1996","unstructured":"Hirai, R. & Fijita, T. A human transforming growth factor-beta type II receptor that contains an insertion in the extracellular domain. Exp. Cell Res. 223, 135\u2013141 (1996).","journal-title":"Exp. Cell Res."},{"key":"1051_CR75","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/1933719117725827","volume":"25","author":"DE Ikhena","year":"2018","unstructured":"Ikhena, D. E. & Bulun, S. E. Literature Review on the Role of Uterine Fibroids in Endometrial Function. Reprod. Sci. 25, 635\u2013643 (2018).","journal-title":"Reprod. Sci."},{"key":"1051_CR76","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1210\/jc.2010-1450","volume":"96","author":"DC Sinclair","year":"2011","unstructured":"Sinclair, D. C., Mastroyannis, A. & Taylor, H. S. Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-beta3. J. Clin. Endocrinol. Metab. 96, 412\u2013421 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1051_CR77","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41591-020-1040-z","volume":"26","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. Single-cell transcriptomic atlas of the human endometrium during the menstrual cycle. Nat. Med. 26, 1644\u20131653 (2020).","journal-title":"Nat. Med."},{"key":"1051_CR78","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","volume":"73","author":"A Arici","year":"2000","unstructured":"Arici, A. & Sozen, I. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil. Steril. 73, 1006\u20131011 (2000).","journal-title":"Fertil. Steril."},{"key":"1051_CR79","first-page":"913","volume":"86","author":"BS Lee","year":"2001","unstructured":"Lee, B. S. & Nowak, R. A. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. J. Clin. Endocrinol. Metab. 86, 913\u2013920 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1051_CR80","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s42003-023-05061-0","volume":"6","author":"EN Paul","year":"2023","unstructured":"Paul, E. N. et al. Cysteine-rich intestinal protein 1 is a novel surface marker for human myometrial stem\/progenitor cells. Commun. Biol. 6, 686 (2023).","journal-title":"Commun. Biol."},{"key":"1051_CR81","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.fertnstert.2012.04.002","volume":"98","author":"SA Salama","year":"2012","unstructured":"Salama, S. A., Diaz-Arrastia, C. R., Kilic, G. S. & Kamel, M. W. 2-Methoxyestradiol causes functional repression of transforming growth factor beta3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells. Fertil. Steril. 98, 178\u2013184 (2012).","journal-title":"Fertil. Steril."},{"key":"1051_CR82","doi-asserted-by":"publisher","first-page":"818243","DOI":"10.3389\/frph.2022.818243","volume":"4","author":"O Uimari","year":"2022","unstructured":"Uimari, O., Subramaniam, K. S., Vollenhoven, B. & Tapmeier, T. T. Uterine Fibroids (Leiomyomata) and Heavy Menstrual Bleeding. Front. Reprod. Health 4, 818243 (2022).","journal-title":"Front. Reprod. Health"},{"key":"1051_CR83","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/humupd\/dmr031","volume":"17","author":"P Ciarmela","year":"2011","unstructured":"Ciarmela, P. et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum. Reprod. Update 17, 772\u2013790 (2011).","journal-title":"Hum. Reprod. Update"},{"key":"1051_CR84","first-page":"383","volume":"3","author":"L Reschke","year":"2022","unstructured":"Reschke, L. et al. Leptin induces leiomyoma cell proliferation and extracellular matrix deposition via JAK2\/STAT3 and MAPK\/ERK pathways. F. S Sci. 3, 383\u2013391 (2022).","journal-title":"F. S Sci."},{"key":"1051_CR85","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","volume":"135","author":"T Geuens","year":"2016","unstructured":"Geuens, T., Bouhy, D. & Timmerman, V. The hnRNP family: insights into their role in health and disease. Hum. Genet 135, 851\u2013867 (2016).","journal-title":"Hum. Genet"},{"key":"1051_CR86","doi-asserted-by":"publisher","unstructured":"Thibault, P. A. et al. hnRNP A\/B Proteins: An Encyclopedic Assessment of Their Roles in Homeostasis and Disease. Biology (Basel) 10, https:\/\/doi.org\/10.3390\/biology10080712 (2021).","DOI":"10.3390\/biology10080712"},{"key":"1051_CR87","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarcon","year":"2015","unstructured":"Alarcon, C. R. et al. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162, 1299\u20131308 (2015).","journal-title":"Cell"},{"key":"1051_CR88","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1242\/jcs.00059","volume":"115","author":"R Pankov","year":"2002","unstructured":"Pankov, R. & Yamada, K. M. Fibronectin at a glance. J. Cell Sci. 115, 3861\u20133863 (2002).","journal-title":"J. Cell Sci."},{"key":"1051_CR89","doi-asserted-by":"publisher","unstructured":"Dalton, C. J. & Lemmon, C. A. Fibronectin: Molecular structure, fibrillar structure and mechanochemical signaling. Cells 10, https:\/\/doi.org\/10.3390\/cells10092443 (2021).","DOI":"10.3390\/cells10092443"},{"key":"1051_CR90","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13046-021-01908-8","volume":"40","author":"S Spada","year":"2021","unstructured":"Spada, S., Tocci, A., Di Modugno, F. & Nistico, P. Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology. J. Exp. Clin. Cancer Res. 40, 102 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1051_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02714-8","volume":"22","author":"S Dorafshan","year":"2022","unstructured":"Dorafshan, S. et al. Periostin: biology and function in cancer. Cancer Cell Int. 22, 315 (2022).","journal-title":"Cancer Cell Int."},{"key":"1051_CR92","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s43032-023-01297-7","volume":"31","author":"ILS Amendola","year":"2024","unstructured":"Amendola, I. L. S., Spann, M., Segars, J. & Singh, B. The Mediator Complex Subunit 12 (MED-12) gene and uterine fibroids: a systematic review. Reprod. Sci. 31, 291\u2013308 (2024).","journal-title":"Reprod. Sci."},{"key":"1051_CR93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s43032-021-00473-x","volume":"29","author":"C He","year":"2022","unstructured":"He, C. et al. Frequency of MED12 mutation in relation to tumor and patient\u2019s clinical characteristics: a meta-analysis. Reprod. Sci. 29, 357\u2013365 (2022).","journal-title":"Reprod. Sci."},{"key":"1051_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.475","volume":"11","author":"MS Islam","year":"2021","unstructured":"Islam, M. S. et al. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids. Clin. Transl. Med. 11, e475 (2021).","journal-title":"Clin. Transl. Med."},{"key":"1051_CR95","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/humupd\/dmx032","volume":"24","author":"MS Islam","year":"2018","unstructured":"Islam, M. S., Ciavattini, A., Petraglia, F., Castellucci, M. & Ciarmela, P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum. Reprod. Update 24, 59\u201385 (2018).","journal-title":"Hum. Reprod. Update"},{"key":"1051_CR96","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.3390\/ijms24065778","volume":"24","author":"Q Yang","year":"2023","unstructured":"Yang, Q. & Al-Hendy, A. Update on the role and regulatory mechanism of extracellular matrix in the pathogenesis of uterine fibroids. Int J. Mol. Sci. 24, 5778 (2023).","journal-title":"Int J. Mol. Sci."},{"key":"1051_CR97","first-page":"900","volume":"79","author":"EA Stewart","year":"1994","unstructured":"Stewart, E. A., Friedman, A. J., Peck, K. & Nowak, R. A. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J. Clin. Endocrinol. Metab. 79, 900\u2013906 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1051_CR98","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1933719107309591","volume":"14","author":"MA Behera","year":"2007","unstructured":"Behera, M. A. et al. Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline. Reprod. Sci. 14, 63\u201376 (2007).","journal-title":"Reprod. Sci."},{"key":"1051_CR99","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3892\/etm.2011.186","volume":"2","author":"M Iwahashi","year":"2011","unstructured":"Iwahashi, M. et al. Immunohistochemical analysis of collagen expression in uterine leiomyomata during the menstrual cycle. Exp. Ther. Med. 2, 287\u2013290 (2011).","journal-title":"Exp. Ther. Med."},{"key":"1051_CR100","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-0030-1251475","volume":"28","author":"M Malik","year":"2010","unstructured":"Malik, M., Norian, J., McCarthy-Keith, D., Britten, J. & Catherino, W. H. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin. Reprod. Med. 28, 169\u2013179 (2010).","journal-title":"Semin. Reprod. Med."},{"key":"1051_CR101","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.fertnstert.2004.04.030","volume":"82","author":"PC Leppert","year":"2004","unstructured":"Leppert, P. C. et al. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil. Steril. 82, 1182\u20131187 (2004).","journal-title":"Fertil. Steril."},{"key":"1051_CR102","first-page":"1495","volume":"27","author":"M Bogusiewicz","year":"2012","unstructured":"Bogusiewicz, M. et al. Expression of matricellular proteins in human uterine leiomyomas and normal myometrium. Histol. Histopathol. 27, 1495\u20131502 (2012).","journal-title":"Histol. Histopathol."},{"key":"1051_CR103","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.fertnstert.2015.12.021","volume":"105","author":"A Patel","year":"2016","unstructured":"Patel, A., Malik, M., Britten, J., Cox, J. & Catherino, W. H. Mifepristone inhibits extracellular matrix formation in uterine leiomyoma. Fertil. Steril. 105, 1102\u20131110 (2016).","journal-title":"Fertil. Steril."},{"key":"1051_CR104","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12957-021-02333-z","volume":"19","author":"X Shen","year":"2021","unstructured":"Shen, X., Yang, Z., Feng, S. & Li, Y. Identification of uterine leiomyosarcoma-associated hub genes and immune cell infiltration pattern using weighted co-expression network analysis and CIBERSORT algorithm. World J. Surg. Oncol. 19, 223 (2021).","journal-title":"World J. Surg. Oncol."},{"key":"1051_CR105","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.rbmo.2018.04.050","volume":"37","author":"GE Courtoy","year":"2018","unstructured":"Courtoy, G. E. et al. Gene expression changes in uterine myomas in response to ulipristal acetate treatment. Reprod. Biomed. Online 37, 224\u2013233 (2018).","journal-title":"Reprod. Biomed. Online"},{"key":"1051_CR106","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.fertnstert.2018.07.024","volume":"110","author":"M Malik","year":"2018","unstructured":"Malik, M., Britten, J., Borahay, M., Segars, J. & Catherino, W. H. Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production. Fertil. Steril. 110, 1398\u20131407.e1391 (2018).","journal-title":"Fertil. Steril."},{"key":"1051_CR107","doi-asserted-by":"publisher","first-page":"633180","DOI":"10.3389\/fcell.2021.633180","volume":"9","author":"A Navarro","year":"2021","unstructured":"Navarro, A., Bariani, M. V., Yang, Q. & Al-Hendy, A. Understanding the impact of uterine fibroids on human endometrium function. Front Cell Dev. Biol. 9, 633180 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"1051_CR108","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Qian, J., Gu, C. & Yang, Y. Alternative splicing and cancer: a systematic review. Signal Transduct. Target Ther. 6, 78 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1051_CR109","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/01677063.2017.1395425","volume":"31","author":"Z Cheng","year":"2017","unstructured":"Cheng, Z., Shang, Y., Gao, S. & Zhang, T. Overexpression of U1 snRNA induces decrease of U1 spliceosome function associated with Alzheimer\u2019s disease. J. Neurogenet. 31, 337\u2013343 (2017).","journal-title":"J. Neurogenet."},{"key":"1051_CR110","doi-asserted-by":"publisher","first-page":"10461","DOI":"10.1073\/pnas.1706076114","volume":"114","author":"KI Takayama","year":"2017","unstructured":"Takayama, K. I. et al. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF. Proc. Natl. Acad. Sci. USA 114, 10461\u201310466 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1051_CR111","first-page":"L173","volume":"268","author":"Y Zhao","year":"1995","unstructured":"Zhao, Y. & Young, S. L. TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. Am. J. Physiol. 268, L173\u2013L180 (1995).","journal-title":"Am. J. Physiol."},{"key":"1051_CR112","doi-asserted-by":"publisher","first-page":"e1265699","DOI":"10.1080\/23723556.2016.1265699","volume":"4","author":"V Tripathi","year":"2017","unstructured":"Tripathi, V. & Zhang, Y. E. Redirecting RNA splicing by SMAD3 turns TGF-beta into a tumor promoter. Mol. Cell Oncol. 4, e1265699 (2017).","journal-title":"Mol. Cell Oncol."},{"key":"1051_CR113","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1093\/emboj\/20.15.4194","volume":"20","author":"S Weg-Remers","year":"2001","unstructured":"Weg-Remers, S., Ponta, H., Herrlich, P. & Konig, H. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J. 20, 4194\u20134203 (2001).","journal-title":"EMBO J."},{"key":"1051_CR114","doi-asserted-by":"publisher","first-page":"25461","DOI":"10.1074\/jbc.M412007200","volume":"280","author":"F Pelisch","year":"2005","unstructured":"Pelisch, F., Blaustein, M., Kornblihtt, A. R. & Srebrow, A. Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK. J. Biol. Chem. 280, 25461\u201325469 (2005).","journal-title":"J. Biol. Chem."},{"key":"1051_CR115","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1093\/hmg\/ddp317","volume":"18","author":"V Goncalves","year":"2009","unstructured":"Goncalves, V., Matos, P. & Jordan, P. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways. Hum. Mol. Genet. 18, 3696\u20133707 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"1051_CR116","doi-asserted-by":"publisher","first-page":"10373","DOI":"10.1093\/nar\/gkz761","volume":"47","author":"JW Chang","year":"2019","unstructured":"Chang, J. W. et al. mTOR-regulated U2af1 tandem exon splicing specifies transcriptome features for translational control. Nucleic Acids Res. 47, 10373\u201310387 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1051_CR117","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1074\/jbc.RA119.011495","volume":"295","author":"FF Lee","year":"2020","unstructured":"Lee, F. F. et al. NF-kappaB mediates lipopolysaccharide-induced alternative pre-mRNA splicing of MyD88 in mouse macrophages. J. Biol. Chem. 295, 6236\u20136248 (2020).","journal-title":"J. Biol. Chem."},{"key":"1051_CR118","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/ijms22020694","volume":"22","author":"WK Chu","year":"2021","unstructured":"Chu, W. K., Hung, L. M., Hou, C. W. & Chen, J. K. PKC regulates YAP expression through alternative splicing of YAP 3\u2019UTR Pre-mRNA by hnRNP F. Int J. Mol. Sci. 22, 694 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"1051_CR119","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0008-8749(03)00127-8","volume":"223","author":"A Iborra","year":"2003","unstructured":"Iborra, A., Mayorga, M., Llobet, N. & Martinez, P. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells. Cell Immunol. 223, 46\u201351 (2003).","journal-title":"Cell Immunol."},{"key":"1051_CR120","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.fertnstert.2006.02.095","volume":"86","author":"RR Nogawa Fonzar-Marana","year":"2006","unstructured":"Nogawa Fonzar-Marana, R. R. et al. Expression of complement system regulatory molecules in the endometrium of normal ovulatory and hyperstimulated women correlate with menstrual cycle phase. Fertil. Steril. 86, 758\u2013761 (2006).","journal-title":"Fertil. Steril."},{"key":"1051_CR121","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1507\/endocrj.K07-073","volume":"55","author":"H Hiroi","year":"2008","unstructured":"Hiroi, H. et al. Expression and regulation of periostin\/OSF-2 gene in rat uterus and human endometrium. Endocr. J. 55, 183\u2013189 (2008).","journal-title":"Endocr. J."},{"key":"1051_CR122","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1177\/1933719115572481","volume":"22","author":"X Xu","year":"2015","unstructured":"Xu, X. et al. Periostin enhances migration, invasion, and adhesion of human endometrial stromal cells through Integrin-Linked Kinase 1\/Akt signaling pathway. Reprod. Sci. 22, 1098\u20131106 (2015).","journal-title":"Reprod. Sci."},{"key":"1051_CR123","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1093\/humrep\/dem216","volume":"22","author":"W Cao","year":"2007","unstructured":"Cao, W., Mah, K., Carroll, R. S., Slayden, O. D. & Brenner, R. M. Progesterone withdrawal up-regulates fibronectin and integrins during menstruation and repair in the rhesus macaque endometrium. Hum. Reprod. 22, 3223\u20133231 (2007).","journal-title":"Hum. Reprod."},{"key":"1051_CR124","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/oxfordjournals.humrep.a019196","volume":"11","author":"DA Bilalis","year":"1996","unstructured":"Bilalis, D. A., Klentzeris, L. D. & Fleming, S. Immunohistochemical localization of extracellular matrix proteins in luteal phase endometrium of fertile and infertile patients. Hum. Reprod. 11, 2713\u20132718 (1996).","journal-title":"Hum. Reprod."},{"key":"1051_CR125","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2119\/molmed.2014.00053","volume":"21","author":"MA Borahay","year":"2015","unstructured":"Borahay, M. A., Al-Hendy, A., Kilic, G. S. & Boehning, D. Signaling pathways in Leiomyoma: Understanding pathobiology and implications for therapy. Mol. Med. 21, 242\u2013256 (2015).","journal-title":"Mol. Med."},{"key":"1051_CR126","doi-asserted-by":"publisher","first-page":"8314","DOI":"10.1073\/pnas.1505421112","volume":"112","author":"F Bordeleau","year":"2015","unstructured":"Bordeleau, F. et al. Tissue stiffness regulates serine\/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors. Proc. Natl. Acad. Sci. USA 112, 8314\u20138319 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1051_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35212-6","volume":"13","author":"MS Islam","year":"2023","unstructured":"Islam, M. S., Parish, M., Brennan, J. T., Winer, B. L. & Segars, J. H. Targeting fibrotic signaling pathways by EGCG as a therapeutic strategy for uterine fibroids. Sci. Rep. 13, 8492 (2023).","journal-title":"Sci. Rep."},{"key":"1051_CR128","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01051-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:44:56Z","timestamp":1757328296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01051-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01051-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.06.578872","asserted-by":"object"}]},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FS, MO, NS, JM, and TMZ are employees and shareholders of Bayer Pharmaceuticals. MP, APC and UO are co-founders of Caeruleus Genomics plc. The study was jointly supported by Oxford and Bayer Healthcare; conceptualisation, research, data analysis and presentation were conducted in an unbiased manner and not influenced by the funding bodies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}